Insulet | PODD - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Abbott USD 5.94B 642M 2026-06
Align Technology USD 298.76M 4.74M 2026-06
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cardinal Health USD 61.23B 2.7B 2026-06
Cooper Companies USD 393.8M 17M 2026-03
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Globus Medical USD 271M 7.41M 2026-06
ICU Medical USD 316.63M 7.37M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
J&J USD 8B 67M 2026-06
Medtronic USD 3.8B 195M 2026-03
Merit Medical Systems USD 203.68M 6.6M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Solventum Corp USD 923M 12M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
West Pharmaceutical Services USD 543.1M 5.4M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06